Antibody Drug Conjugate

Antibody-drug conjugates or ADCs are a new class of highly potent biopharmaceutical drugs designed as a targeted therapy for the treatment of people with cancer. By combining the unique targeting capabilities of monoclonal antibodies with the cancer-killing ability of cytotoxic drugs, antibody-drug conjugates allow sensitive discrimination between healthy and diseased tissue. This means that, in contrast to traditional chemotherapeutic agents, antibody-drug conjugates target and attack the cancer cell so that healthy cells are less severely affected. The biochemical reaction between the antibody and the target protein (antigen) triggers a signal in the tumor cell, which then absorbs or internalizes the antibody together with the cytotoxin. A stable link between the antibody and cytotoxic (anti-cancer) agent is a crucial aspect of an ADC.

Linkers are based on chemical motifs including disulfides, hydrazones or peptides (cleavable), or thioethers (noncleavable) and control the distribution and delivery of the cytotoxic agent to the target cell. Cleavable and noncleavable types of linkers have been proven to be safe in preclinical and clinical trials.

    Related Conference of Antibody Drug Conjugate

    September 13-14, 2018

    11th Annual Congress on Immunology & Immunotechnology

    Zurich, Switzerland
    September 17-18, 2018

    3rd International Conference on Tumor & Cancer Immunology and Immunotherapy

    San Diego, California, USA
    September 17-18, 2018

    3rd International Conference on Tumor & Cancer Immunology and Immunotherapy

    San Diego, California, USA
    October 19-20, 2018

    10th World Congress and Expo on Immunology

    New York, USA
    October 29-30, 2018

    6th International Conference on HIV/AIDS, STDs and STIs

    San Francisco, USA
    November 22-23, 2018

    World Conference on Vaccine and Immunology

    Bucharest, Romania
    November 26-27, 2018

    3rd International Conference on Autoimmunity

    Dublin, Ireland
    December 05-06, 2018

    Global Meet on Immunology, Hematology and Molecular Biology

    Portugal, Lisbon
    December 06-08, 2018

    Annual Congress and Expo on Antibiotics

    Amsterdam, Netherlands
    March 04-05, 2019

    10th Molecular Immunology & Immunogenetics Congress

    Barcelona, Spain
    March 18-19, 2019

    11th Global Summit on Immunology and Cell Biology

    Sydney, Australia
    June 13-14, 2019 |

    10th European Immunology Conference

    Berlin, Germany
    July 29-30 2018

    6th International Conference on Parasitology & Microbiology

    Amsterdam, Netherlands

    Antibody Drug Conjugate Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in